Biotech News

embecta to Participate in Investor Events

Embecta (EMBC)Embecta2026-06-01 21:00 ESTCompany update

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor

Related news

EMBCEmbecta2026-05-08 13:00 EST

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

BLTEBelite Bio2026-07-06 12:00 EST

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

NAMSNewAmsterdam Pharma2026-05-28 12:00 EST

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June

VKTXViking Therapeutics2026-05-21 11:05 EST

Viking Therapeutics to Participate at Upcoming Investor Conferences

SGMTSagimet Biosciences2026-05-13 11:00 EST

Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

NAMSNewAmsterdam Pharma2026-05-11 12:41 EST

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May

BLTEBelite Bio2026-04-23 12:00 EST

Belite Bio to Participate in Four Upcoming Investor Conferences

ALTAltimmune2026-05-27 12:30 EST

Altimmune to Participate in Upcoming Investor Conferences

SGMTSagimet Biosciences2026-08-04 11:00 EST

Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

View all latest news

Embecta

Global Diabetes Care Embecta is a global diabetes-care company built on a nearly century-long history in insulin delivery. Its products are used by people who self-administer injectable therapies and by healthcare systems supporting diabetes management. Injection-Device Portfolio The company's core portfolio includes pen needles and...

Recent company news

EMBCEmbecta2026-08-07 10:30 EST

Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results

EMBCEmbecta2026-08-07 10:00 EST

embecta Announces Quarterly Cash Dividend

EMBCEmbecta2026-07-23 21:00 EST

embecta to Report Fiscal Third Quarter Financial Results

EMBCEmbecta2026-06-16 10:30 EST

embecta appoints Nimish Muzumdar as SVP and President, North America

EMBCEmbecta2026-06-01 21:00 EST

embecta to Participate in Investor Events

Stock data

Close: 3.50 USD
Market cap: 207.05M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States